Skip to main content

Insulin and Lung Development

  • Chapter
Book cover Endocrinology of the Lung

Abstract

Infants of diabetic mothers have an elevated incidence of respiratory distress syndrome of the newborn (RDS), a disease which is caused by pulmonary surfactant deficiency associated with inadequate numbers of differentiated alveolar type II cells in the lung (1,2). Pulmonary surfactant, which functions to reduce surface tension at the air-alveolar interface, is made up of glycerophospholipids (approx 80% by weight), cholesterol (approx 10%) and the surfactant-associated proteins (approx 10%) (3). The fetus of the diabetic mother tends to have high serum glucose and insulin levels as a result of maternal hyperglycemia (4). Robert et al. (1) first advanced the hypothesis that high levels of insulin might delay lung development in the fetus of the gestational diabetic woman. In this chapter, we will review the literature concerning the effects f maternal diabetes, glucose, and, in particular, insulin on fetal lung development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robert MF, Neff RK, Hubbell JP, Taeusch, HW, Avery ME. Association between maternal diabetes and the respiratory distress syndrome in the newborn. N Engl J Med 1976; 294: 357–360.

    PubMed  CAS  Google Scholar 

  2. Avery ME, Mead J. Surface properties in relation to aletectasis and hyaline membrane disease. Am J Dis Child 1959; 97: 517–523.

    CAS  Google Scholar 

  3. Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis 1987; 136: 426–444.

    PubMed  CAS  Google Scholar 

  4. Pedersen J, Osler M. Hyperglycemia as the cause of characteristic features of the fetus and newborn diabetic mothers. Dan Med Bull 1961; 8: 78–83.

    PubMed  CAS  Google Scholar 

  5. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am 1996; 23: 221–241.

    PubMed  CAS  Google Scholar 

  6. Gluck L, Kulovich MV. Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973; 115: 539–546.

    PubMed  CAS  Google Scholar 

  7. Frantz ID III Epstein MF. Fetal lung development in pregnancies complicated by diabetes. In: Merkatz IR, Adam PAJ, eds. The diabetic pregnancy: a perinatal perspective; New York: Grune & Stratton, 1979: 227–233.

    Google Scholar 

  8. Mimouni F, Miodovnik M, Whitsett JA, Holroyde JC, Siddiqi TA, Tsang RC. Respiratory distress syndrome in infants of diabetic mothers in the 1980s: no direct adverse effect of maternal diabetes with modern management. Obstet Gynecol 1987; 69: 191–195.

    PubMed  CAS  Google Scholar 

  9. Bradley R. Diabetic pregnancy. Hosp Med 1990; 44: 386–390.

    CAS  Google Scholar 

  10. Heding LG, Persson B, Stangenberg M. ß cell function in newborn infants of diabetic mothers. Diabetologia 1980; 19: 427–432.

    PubMed  CAS  Google Scholar 

  11. Sosenko IR, Kitzmiller JL, Loo SW, Blix P, Rubenstein AH, Gabbay KH. The infant of the diabetic mother. Correlation of increased cord C-peptide levels with macrosomia and hypoglycemia. N Engl J Med 1979; 301: 859–862.

    PubMed  CAS  Google Scholar 

  12. Obenshain SS, Adam PAJ, King KC, Teramo K, Raivio KO, Raiha N, Schwartz R. Human fetal insulin response to sustained maternal hyperglycemia. N Engl J Med 1970; 283: 566–570.

    PubMed  CAS  Google Scholar 

  13. Knip M, Lautala P, Leppaluoto J, Akerblom HK, Kouvalainen K. Relation of enteroinsular hormones at birth to macrosomia and neonatal hypoglycemia in infants of diabetic mothers. J Pediatr 1983; 103: 603–611.

    PubMed  CAS  Google Scholar 

  14. Isles TE, Dickon M, Farguhar JW. Glucose tolerance and plasma insulin in newborn infants of normal and diabetic mothers. Pediatr Res 1968; 2: 198–208.

    PubMed  CAS  Google Scholar 

  15. Karlsson K Kjellmer I. The outcome of diabetic pregnancies in relation to the mother’s blood sugar level. Am J Obstet Gynecol 1972; 112: 213–220.

    PubMed  CAS  Google Scholar 

  16. Mallampalli RK, Acarregui MJ, Snyder JM. Differentiation of the alveolar epithelium in the fetal lung. In: McDonald JA, ed. Lung growth and development. New York: Marcel Dekker, 1997: 119–162.

    Google Scholar 

  17. Gluck L, Kulovich MV, Borer RC Jr, Keidel WN. The interpretation and significance of the L/S ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120: 142–155.

    PubMed  CAS  Google Scholar 

  18. Whitfield CR, Sproule WB, Brudenell M. The amniotic fluid lecithin: sphingomyelin area ratio (LSAR) in pregnancies complicated by diabetes. J Obstet Gynecol Br Comw 1973; 80: 918–922.

    CAS  Google Scholar 

  19. Singh EJ, Mejia A, Zuspan FP. Studies of human amniotic fluid phospholipids in normal, diabetic and drug-abuse pregnancy. Am J Obstet Gynecol 1974; 119: 623–629.

    PubMed  CAS  Google Scholar 

  20. Merola JC, Johnson LM, Bolognese RJ, Corson SL. Determination of fetal pulmonary maturity by amniotic fluid lecithin/sphingomyelin ratio and rapid shake test. Am J Obstet Gynecol 1974; 119: 243–252.

    PubMed  CAS  Google Scholar 

  21. Dyson D, Blake M, Cassady G. Amniotic fluid lecithin/sphingomyelin ratio in complicated pregnancies. Am J Obstet Gynecol 1975; 122: 772–781.

    PubMed  CAS  Google Scholar 

  22. Skjæraasen J, Lindback T. Phospholipid concentrations in amniotic fluid from diabetic pregnant women. Acta Obstet Gynecol Scand 1976; 55: 225–232.

    PubMed  Google Scholar 

  23. Cunningham MD, Desai NS, Thompson SA, Greene JM Amniotic fluid phosphatidylglycerol in diabetic pregnancies. Am J Obstet Gynecol 1978; 131: 719–724.

    PubMed  CAS  Google Scholar 

  24. Curet LB, Olson RW, Schneider JM, Zachman RD. Effects of diabetes mellitus on amniotic fluid L/ S ratio and respiratory distress syndrome. Am J Obstet Gynecol 1979; 135: 10–13.

    PubMed  CAS  Google Scholar 

  25. Kulovich MV, Gluck L. The lung profile II: complicated pregnancy. Am J Obstet Gynecol 1979; 135: 64–70.

    PubMed  CAS  Google Scholar 

  26. Hallman M, Teramo K. Amniotic fluid phospholipid profile as a predictor of fetal maturity in diabetic pregnancies. Obstet Gynecol 1979; 54: 703–707.

    PubMed  CAS  Google Scholar 

  27. Tsai MY, Shultz EK, Nelson JA. Amniotic fluid phosphatidylglycerol in diabetic and control pregnant patients at different gestational lengths. Am J Obstet Gynecol 1984; 149: 388–392.

    PubMed  CAS  Google Scholar 

  28. Farrell PM, Engle MJ, Curet LB, Perelman RH, Morrison JC. Saturated phospholipids in amniotic fluid of normal and diabetic pregnancies. Obstet Gynecol 1984; 64: 77–85.

    PubMed  CAS  Google Scholar 

  29. Tydén O, Berne C, Eriksson UJ, Hansson U, Stangenberg M, Persson B. Fetal maturation in strictly controlled diabetic pregnancy. Diabetes Res 1984; 1: 131–134.

    PubMed  Google Scholar 

  30. McMahan MJ, Mimouni F, Miodovnik M, Hull WM, Whitsett JA. Surfactant associated protein (SAP-35) in amniotic fluid from diabetic and non-diabetic pregnancies. Obstet Gynecol 1987; 70: 94–98.

    PubMed  CAS  Google Scholar 

  31. Curet LB, Tsao FH, Zachman RD, Olson RW, Henderson PA. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies. Int J Obstet Gynecol 1989; 30: 105–108.

    CAS  Google Scholar 

  32. Snyder JM, Kwun JE, O’ Brien JA, Rosenfeld CR, Odom MJ. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res 1988; 24: 728–734.

    PubMed  CAS  Google Scholar 

  33. Piper JM, Samueloff A, Langer O. Outcome of amniotic fluid analysis and neonatal respiratory status in diabetic and non-diabetic pregnancies. J Reprod Med 1995; 40: 780–784.

    PubMed  CAS  Google Scholar 

  34. Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation: comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997; 42: 793–800.

    PubMed  CAS  Google Scholar 

  35. Donald IR, Freeman RK, Goebelsmann U, Chan WH, Nakamura RM. Clinical experience with the amniotic fluid lecithin/sphingomyelin ratio.1. Antenatal prediction of pulmonary maturity. Am J Obstet Gynecol 1973; 115: 547–552.

    PubMed  CAS  Google Scholar 

  36. Cruz AC, Buki WC, Birk SA, Spellacy WN. Respiratory distress syndrome with mature lecithin/ spingomyelin ratios: diabetes mellitus and low Apgar scores. Am J Obstet Gynecol 1975; 126: 78–82.

    Google Scholar 

  37. Andrews AG, Brown JB, Jeffery PE, Horacek I. Amniotic fluid palmitic acid/stearic acid ratios. Lecithin/sphingomyelin ratios and palmitic acid concentrations in the assessment of fetal lung maturity in diabetic pregnancies. Br J Obstet Gynecol 1979; 86: 959–964.

    CAS  Google Scholar 

  38. Katyal SL, Amenta JS, Singh G, Silverman JA. Deficient lung surfactant apoproteins in amniotic fluid with mature phospholipid profile from diabetic pregnancies. Am J Obstet Gynecol 1984; 148: 42–53.

    Google Scholar 

  39. Hallman M, Kulovich M, Kirkpatrick E, Sugarman RG, Gluck L. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125: 613–617.

    PubMed  CAS  Google Scholar 

  40. Bleasdale JE, Mayberry MC, Quirk JG. Myo-inositol homeostasis in fetal rabbit lung. Biochem J 1982; 206: 43–52.

    PubMed  CAS  Google Scholar 

  41. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 1991; 273: 249–264.

    PubMed  CAS  Google Scholar 

  42. Snyder JM, Mendelson CR. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro. Endocrinology 1987; 120: 1250–1257.

    PubMed  CAS  Google Scholar 

  43. King RJ, Ruch J, Gikas EG, Platzker AC, Creasy RK. Appearance of apoproteins of pulmonary surfactant in human amniotic fluid. Appl J Physiol 1975; 39: 735–741.

    CAS  Google Scholar 

  44. Smith BT, Giroud CJ, Robert M, Avery ME. Insulin antagonism of cortisol action on lecithin synthesis by cultured fetal lung cells. J Pediatr 1975; 87: 953–955.

    PubMed  CAS  Google Scholar 

  45. Ballard PL. Hormonal regulation of pulmonary surfactant. Endocr Rev 1989; 10: 165–181.

    PubMed  CAS  Google Scholar 

  46. Neufeld ND, Sevanian A, Barrett CT, Kaplan SA. Inhibition of surfactant production by insulin in fetal rabbit lung slices. Pediatr Res 1979; 13: 752–754.

    PubMed  CAS  Google Scholar 

  47. Engle MJ, Langan SM, Sanders RL. The effects of insulin and hyperglycemia on surfactant phospholipid synthesis in organotypic cultures of type II pneumoncytes. Biochim Biophys Acta 1983; 753: 6–13.

    PubMed  CAS  Google Scholar 

  48. Gross I, Smith GJ, Wilson CM, Maniscalco WM, Ingleson LD, Brehier A, Rooney SA. The influence of hormones on the biochemical development of fetal rat lung in organ culture. II. Insulin. Pediatr Res 1980; 14: 834–838.

    CAS  Google Scholar 

  49. Bourbon JR, Rieutort M, Engle MJ, Farrell PM. Utilization of glycogen for phospholipid synthesis in fetal rat lung. Biochim Biophys Acta 1982; 712: 382–389.

    PubMed  CAS  Google Scholar 

  50. Mendelson CR, Johnston JM, MacDonald PC, Snyder JM. Multihormonal regulation of surfactant synthesis by human fetal lung in vitro. J Clin Endocrinol Metab 1981; 53: 307–317.

    PubMed  CAS  Google Scholar 

  51. Snyder JM, Longmuir KJ, Johnston JM, Mendelson CR. Hormonal regulation of the synthesis of lamellar body phosphatidylglycerol and phosphatidylinositol in fetal lung tissue. Endocrinology 1983; 112: 1012–1018.

    PubMed  CAS  Google Scholar 

  52. Hallman M, Wermer D, Epstein BL, Gluck L. Effects of maternal insulin or glucose infusion on the fetus: study on lung surfactant phospholipids, plasma myoinositol and fetal growth in the rabbit. Am J Obstet Gynecol 1982; 142: 877–882.

    PubMed  CAS  Google Scholar 

  53. Levine DH. Hyperinsulinemia and decreased surfactant in fetal rabbits. Dev Pharmacol Ther 1985; 8: 284–291.

    PubMed  CAS  Google Scholar 

  54. Pignol B, Bourbon J, Ktorza A, Marin L, Rieutort M, Tordet C. Lung maturation in the hyperinsulinemic rat fetus. Pediatr Res 1987; 21: 436–441.

    PubMed  CAS  Google Scholar 

  55. Warburton D, Lew CD, Platzker AC. Primary hyperinsulinemia reduces surface active material flux in tracheal fluid of fetal lambs. Pediatr Res 1981; 15: 1422–1424.

    PubMed  CAS  Google Scholar 

  56. Warburton D. Chronic hyperglycemia with secondary hyperinsulinemia inhibits the maturational response of fetal lamb lungs to cortisol. J Clin Invest 1983; 72: 433–440.

    PubMed  CAS  Google Scholar 

  57. Rooney SA, Chu AJ, Gross I, Marino PA, Schwartz R, Seghal P, Singer DB, Susa JB, Warshaw JB, Wilson CM. Lung surfactant in the hyperinsulinemic fetal monkey. Lung 1983; 161: 313–317.

    PubMed  CAS  Google Scholar 

  58. Bose CL, Manne DN, D’Ercole AJ, Lawson EE. Delayed fetal pulmonary maturation in a rabbit model of the diabetic pregnancy. J Clin Invest 1980; 66: 220–226.

    PubMed  CAS  Google Scholar 

  59. Sosenko IR, Lawson EE, Demottag V, Frantz ID III. Functional delay in lung maturation in fetuses of diabetic rats. J Appl Physiol 1980; 48: 643–647.

    PubMed  CAS  Google Scholar 

  60. Sosenko IR, Frantz ID III, Roberts RJ, Meyrick B. Morphologic distrubance of lung maturation in fetuses of alloxan diabetic rabbits. Am Rev Respir Dis 1980; 122: 687–695.

    PubMed  CAS  Google Scholar 

  61. Sosenko IR, Hartig-Beecken I, Frantz ID III. Cortisol reversal of functional delay of lung maturation in fetuses of diabetic rabbits. J Appl Physiol 1980; 49: 971–974.

    PubMed  CAS  Google Scholar 

  62. Bhavnani BR, Enhorning G, Ekelund L, Wallace D, Pan CC. Maternal diabetes and its effect on biochemical and functional development of rabbit fetal lung. Biochem Cell Biol 1988; 66: 396–404.

    PubMed  CAS  Google Scholar 

  63. Epstein MF, Farrell PM, Chey RA. Fetal lung lecithin metabolism in the glucose-intolerant rhesus monkey pregnancy. Pediatrics 1976; 57: 722–728.

    PubMed  CAS  Google Scholar 

  64. Tyden O, Berne C, Eriksson U. Lung maturation in fetuses of diabetic rats. Pediatr Res 1980; 14: 1192–1195.

    PubMed  CAS  Google Scholar 

  65. Tsai MY, Josephson MW, Brown DM. Fetal rat lung phosphatidylcholine synthesis in diabetic and normal pregnancies: a comparison of prenatal dexamethasone treatments. Biochim Biophys Acta 1981; 664: 174–181.

    PubMed  CAS  Google Scholar 

  66. Mulay S, McNaughton L. Fetal lung development in streptozotocin-induced experimental diabetes: cytidylyl transferase activity, disaturated phosphatidylcholine and glycogen levels. Life Sci 1983; 33: 637–644.

    PubMed  CAS  Google Scholar 

  67. Eriksson UJ, Tyden O, Berne C. Development of phosphatidyl glycerol biosynthesis in the lungs of fetuses of diabetic rats. Diabetologia 1983; 24: 202–206.

    PubMed  CAS  Google Scholar 

  68. Eriksson UJ, Tyden O, Berne C. Glycogen content and lipid biosynthesis in the lungs of fetuses of diabetic rats. Biol Res Pregn 1983; 4: 103–106.

    CAS  Google Scholar 

  69. Gewolb IH, Rooney SA, Barrett C, Ingleson LD, Light D, Wilson CM, Walker Smith GJ, Gross I, Warshaw JB. Delayed pulmonary maturation in the fetus of the streptozotocin-diabetic rat. Exp Lung Res 1985; 8: 141–151.

    PubMed  CAS  Google Scholar 

  70. Rotenberg M, Gewolb IH. Reversal of lung maturation delay in the fetus of the diabetic rat using triiodo-thyronine or dexamethasone. Biol Neonate 1993; 64: 318–324.

    PubMed  CAS  Google Scholar 

  71. Bourbon JR, Pignol B, Marin L, Rieutort M, Tordet C. Maturation of fetal rat lung in diabetic pregnancies of graduated severity. Diabetes 1985; 34: 734–743.

    PubMed  CAS  Google Scholar 

  72. Gewolb IH. High glucose causes delayed fetal lung maturation in vitro. Exp Lung Res 1993; 19: 619–630.

    PubMed  CAS  Google Scholar 

  73. Gewolb IH. Effect of high glucose on fetal lung maturation at different times in gestation. Exp Lung Res 1996; 22: 201–211.

    PubMed  CAS  Google Scholar 

  74. Gewolb IH, Torday JS. High glucose inhibits maturation of the fetal lung in vitro: morphometric analysis of lamellar bodies and fibroblast lipid inclusions. Lab Invest 1995; 73: 59–63.

    PubMed  CAS  Google Scholar 

  75. Gewolb IH, O’Brien J. Surfactant secretion by type II pneumonocytes is inhibited by high glucose concentrations. Exp Lung Res 1997; 23: 245–255.

    PubMed  CAS  Google Scholar 

  76. Dekowski SA, Snyder JM. Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology 1992; 131: 669–676.

    PubMed  CAS  Google Scholar 

  77. Dekowski SA, Snyder JM. The combined effects of insulin and cortisol on surfactant protein mRNA levels. Pediatr Res 1995; 38: 513–521.

    PubMed  CAS  Google Scholar 

  78. Katyal SL, Singh G, Locker J. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am J Respir Cell Mol Biol 1992; 6: 446–452.

    PubMed  CAS  Google Scholar 

  79. Kumar AR, Snyder JM. Differential regulation of SP-A 1 and SP-A2 genes by cAMP, glucocorticoids and insulin. Am J Physiol 1998; 274: L177 - L185.

    PubMed  CAS  Google Scholar 

  80. Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochim Biophys Acta 1998; 1442: 60–70.

    PubMed  CAS  Google Scholar 

  81. Guttentag SH, Phelps DS, Stenzel W, Warshaw JB, Floros J. Surfactant protein A expression is delayed in fetuses of streptozotocin-treated rats. Am J Physiol 1992; 262: L489 - L494.

    PubMed  CAS  Google Scholar 

  82. Guttentag SH, Phelps DS, Warshaw JB, Floros J. Delayed hydrophobic surfactant protein SP-B, SP-C; expression in fetuses of streptozotocin-treated rats. Am J Respir Cell Mol Biol 1992; 7: 190–197.

    PubMed  CAS  Google Scholar 

  83. Rayani HH, Warshaw JB, Floros J. Dexamethasone enhances surfactant protein gene expression in streptozotocin-induced immature rat lungs. Pediatr Res 1995; 38: 870–877.

    PubMed  CAS  Google Scholar 

  84. Moglia BB Phelps DS. Changes in surfactant protein A mRNA levels in a rat model of insulin-treated diabetic pregnancy. Pediatr Res 1996; 39: 241–247.

    PubMed  CAS  Google Scholar 

  85. Tavare JM, Siddle K. Mutational analysis of insulin receptor function: consensus and controversy. Biochim Biophys Acta 1993; 1178: 21–39.

    PubMed  CAS  Google Scholar 

  86. Snyder JM, D’Ercole, AJ. Somatomedin C/insulin-like growth factor I production by human fetal lung tissue maintained in vitro. Exp Lung Res 1987; 13: 449–458.

    PubMed  CAS  Google Scholar 

  87. Benito M, Valverde AM, Lorenzo M. IGF-I: a mitogen also involved in differentiation processes in mammalian cells. Int J Biochem Cell Biol 1996; 28: 499–510.

    PubMed  CAS  Google Scholar 

  88. Saltiel AR. Diverse signaling pathways in the cellular actions of insulin. Am J Physiol 1996; 270: E375 - E385.

    PubMed  CAS  Google Scholar 

  89. Ulane RE, Graeber JE, Hansen JW, Liccini L, Cornblath M. Insulin receptors in the developing fetal lung. Life Sci 1982; 31: 3017–3022.

    PubMed  CAS  Google Scholar 

  90. Ulane RE, Graeber JE, Steinherz RA. A comparison of insulin receptors in the developing fetal lung in normal and in streptozotocin-induced diabetic pregnancies. Pediatr Pulmonol 1985; 1 (3 Suppl): S86 - S90.

    PubMed  CAS  Google Scholar 

  91. Mulay S, Philip A, Solomon S. Influence of maternal diabetes on fetal rat development: alteration of insulin receptors in fetal liver and lung. J Endocrinol 1983; 98: 401–410.

    PubMed  CAS  Google Scholar 

  92. Gewolb IH, O’Brien J, Palese TA, Phillip M. High glucose and insulin decrease fetal lung insulin receptor mRNA and tyrosine kinase activity in vitro Biochem Biophys Res Commun 1994; 202: 694–700.

    CAS  Google Scholar 

  93. Devaskar SU, Ganguli S, Devaskar UP, Sperling MA. Glucocorticoids and hypothyroidism modulate development of fetal lung insulin receptors. Am J Physiol 1982; 242: E384 - E391.

    PubMed  CAS  Google Scholar 

  94. Kaplan SA, Barrett CT, Scott ML, Whitson RH. Insulin receptors in fetal rabbit lung type II cells. Endocrinology 1984; 114: 2199–2204.

    PubMed  CAS  Google Scholar 

  95. Duvillie B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, Monthioux E, Jami J, Joshi RL, Bucchini D. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci 1997; 94: 5137–5140.

    PubMed  CAS  Google Scholar 

  96. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Gen 1996; 12: 106–109.

    CAS  Google Scholar 

  97. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 1996; 15: 1542–1547.

    PubMed  CAS  Google Scholar 

  98. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Gen 1993; 5: 71–73.

    CAS  Google Scholar 

  99. Krook A, Brixton L, O’Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 1993; 342: 277–278.

    PubMed  CAS  Google Scholar 

  100. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609–2617.

    PubMed  CAS  Google Scholar 

  101. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 1993; 75: 59–72.

    PubMed  CAS  Google Scholar 

  102. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991; 64: 849–859.

    PubMed  CAS  Google Scholar 

  103. Wang ZQ, Fung MR, Barlow DP, Wagner EF. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 1994; 372: 464–467.

    PubMed  CAS  Google Scholar 

  104. Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997; 423: 39–45.

    PubMed  CAS  Google Scholar 

  105. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chretien M, Butler MG. An infant with deletion of the distal long arm of chromosome 15 (q261-qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Gen 1991; 38: 74–79.

    CAS  Google Scholar 

  106. Siebler T, Lopaczynski W, Terry CL, Casella SJ, Munson P, De Leon DD, Phang L, Blakemore KJ, McEvoy RC, Kelley RI, Nissley P. Insulin-like growth factor 1 receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. J Clin Endocrinol Metabol 1995; 80: 3447–3457.

    CAS  Google Scholar 

  107. Tamura T, Tohma T, Ohta T, Soejima H, Harada N, Abe K, Niikawa N. Ring chromosome 15 involving deletion of the insulin-like growth factor 1 receptor gene in a patient with features of Silver-Russell syndrome. Clin Dysmorphol 1993; 2: 106–113.

    PubMed  CAS  Google Scholar 

  108. Baba T, Kinoshita E, Matsumoto T, Yoshimoto M, Tsuji Y, Sasaoka K, Kamijo T. Decrease of insulin-like growth factor I receptor in patients with ring chromosome 15. Pediatr Res 1993;(33Suppl 5 ): S53.

    Google Scholar 

  109. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus: pneumonia. Infect Dis Clin North Am 1995; 9: 65–96.

    PubMed  CAS  Google Scholar 

  110. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19: 177–201.

    PubMed  CAS  Google Scholar 

  111. Bagdadel JD, Nelson KL, Bulger RJ. Reversible abnormalities of phagocytic function in poorly controlled diabetic patients. Am J Med Sci 1972; 263: 451–456.

    Google Scholar 

  112. Rayfield EJ, Ault MJ, Keusch GT. Infection and diabetes: the case for glucose control. Am J Med 1982; 72: 439–50.

    PubMed  CAS  Google Scholar 

  113. Hill HR, Augustine NH, Rallison ML, Santos H. Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 1983; 3: 70–77.

    PubMed  CAS  Google Scholar 

  114. Saiki O, Negoro S, Tsuyuguchi I. Depressed immunological defense mechanisms in mice with experimentally induced diabetes. Infect Immun 1980; 28: 127–131.

    PubMed  CAS  Google Scholar 

  115. Woodhead MA, MacFarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671–674.

    PubMed  CAS  Google Scholar 

  116. Uhal BD, Longmore WJ. Altered phospholipid biosynthesis in type II pneumocytes isolated from streptozotocin-diabetic rats. Biochim Biophys Acta 1986; 878: 266–272.

    PubMed  CAS  Google Scholar 

  117. Sugahara K, lyama K-I, Sano K, Morioka T. Overexpression of pulmonary surfactant apoprotein A mRNA in alveolar type II cells and nonciliated bronchiolar Clara; epithelial cells in streptozotocininduced diabetic rats demonstrated by in situ hybridization. Am J Respir Cell Mol Biol 1992; 6: 307–314.

    PubMed  CAS  Google Scholar 

  118. Strojek K, Ziora D, Sroczynski JW, Oklek K. Pulmonary complication of type-1 (insulin-dependent) diabetic patients. Diabetology 1992; 35: 1173–1176.

    CAS  Google Scholar 

  119. Walton S, Byrd RR Jr, Fields CL, Ossorio MA, Roy TM. Abnormal pulmonary function and juvenile onset diabetes mellitus. Kentucky Med Assoc J 1994; 92: 101–104.

    CAS  Google Scholar 

  120. Antonelli IR, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794–2800.

    Google Scholar 

  121. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 51: 684–687.

    Google Scholar 

  122. Lange P, Groth S, Mortensen J, Appleyard M, Nyboe J, Schnohr P, Jensen G. Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Resp J 1990; 3: 288–292.

    CAS  Google Scholar 

  123. Heinemann L, Traut T, Heise T. Time-action profile of inhaled insulin. Diabetic Med 1997; 14: 63–72.

    PubMed  CAS  Google Scholar 

  124. Elliott RB, Edgar BW, Filcher CC, Quested C, McMaster J. Parenteral absorption of insulin from the lung in diabetic children. Aust Pediatr J 1987; 23: 293–297.

    CAS  Google Scholar 

  125. Laube BL, Georgopoulos A, Adams III GK. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patient. JAMA 1993; 269: 2106–2109.

    PubMed  CAS  Google Scholar 

  126. Effros RM. Permeability of the blood-gas barrier. In: Crystal RG, ed. The lung: scientific foundations. Philadelphia: Lippincott-Raven, 1997: 1567–1580.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.Totowa,NJ

About this chapter

Cite this chapter

Snyder, J.M., George, T.N., Miakotina, O.L. (2000). Insulin and Lung Development. In: Mendelson, C.R. (eds) Endocrinology of the Lung. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-014-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-014-8_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9608-6

  • Online ISBN: 978-1-59259-014-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics